PTC Therapeutics, Inc.: 10-Q filed 2013-08-13
What PTC Therapeutics, Inc. reported in its quarterly report filed 2013-08-13 (fiscal Q2 2013): 30 published measures, 87 facts as tagged in accession 0001104659-13-062994.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-08-13
- Fiscal period
- fiscal Q2 2013
- Accession
- 0001104659-13-062994 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PTC Therapeutics, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 175,468,084 | USD | |
| At 2012-12-31 | 13,072,352 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 22,548,444 | USD | |
| At 2012-12-31 | 31,889,085 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 152,919,640 | USD | |
| At 2012-12-31 | -99,640,501 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 154,095,269 | USD | |
| At 2012-12-31 | 2,725,702 | USD | |
| At 2012-06-30 | 22,248,613 | USD | |
| At 2011-12-31 | 28,431,410 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -14,586,578 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -29,271,113 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -6,068,072 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -12,665,933 | USD | 182 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 95,791 | USD | 181 |
| 2012-01-01 to 2012-06-30 | 179,218 | USD | 182 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | -306,495,831 | USD | |
| At 2012-12-31 | -277,224,718 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 2,648,832 | shares | 91 |
| 2013-01-01 to 2013-06-30 | 1,326,679 | shares | 181 |
| 2012-04-01 to 2012-06-30 | 3,091 | shares | 91 |
| 2012-01-01 to 2012-06-30 | 2,095 | shares | 182 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 2,648,832 | shares | 91 |
| 2013-01-01 to 2013-06-30 | 1,326,679 | shares | 181 |
| 2012-04-01 to 2012-06-30 | 10,753 | shares | 91 |
| 2012-01-01 to 2012-06-30 | 5,926 | shares | 182 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -5.51 | USD/shares | 91 |
| 2013-01-01 to 2013-06-30 | -33.26 | USD/shares | 181 |
| 2012-04-01 to 2012-06-30 | 168 | USD/shares | 91 |
| 2012-01-01 to 2012-06-30 | 133.35 | USD/shares | 182 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -5.51 | USD/shares | 91 |
| 2013-01-01 to 2013-06-30 | -33.26 | USD/shares | 181 |
| 2012-04-01 to 2012-06-30 | 48.29 | USD/shares | 91 |
| 2012-01-01 to 2012-06-30 | 47.14 | USD/shares | 182 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 7,153,532 | USD | |
| At 2012-12-31 | 8,280,037 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 2,502,490 | USD | 181 |
| 2012-01-01 to 2012-06-30 | 1,295,322 | USD | 182 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -14,452,936 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -23,029,345 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -7,498,207 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -13,718,444 | USD | 182 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 168,158,078 | USD | |
| At 2012-12-31 | 4,595,265 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 19,788,489 | USD | |
| At 2012-12-31 | 28,158,889 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 425,424 | USD | |
| At 2012-12-31 | 621,591 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 21,307,148 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 37,025,221 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 15,083,384 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 33,829,341 | USD | 182 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 14,712,091 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 25,968,919 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 11,918,999 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 26,222,332 | USD | 182 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 23,803,282 | shares | |
| At 2012-12-31 | 4,526 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 459,391,899 | USD | |
| At 2012-12-31 | 177,583,672 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | -772 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 2,518,288 | USD | |
| At 2012-12-31 | 2,549,719 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 1,609,382 | USD | |
| At 2012-12-31 | 855,750 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -14,586,578 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -44,129,131 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 153,508,210 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 146,910,349 | USD | 182 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -14,587,350 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -29,271,885 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -6,068,072 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -12,665,933 | USD | 182 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -14,586,578 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -44,129,131 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 519,233 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 279,370 | USD | 182 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 6,595,057 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 11,056,302 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 3,164,385 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 7,607,009 | USD | 182 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 1,222,294 | USD | 181 |
| 2012-01-01 to 2012-06-30 | 1,381,263 | USD | 182 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -19,469 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 34,461 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 1,765,216 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 1,812,772 | USD | 182 |
Inspect the source
- Entity
- PTC Therapeutics, Inc. / CIK 0001070081
- Captured
- 2026-09-20T05:19:30.322Z
- SEC response SHA-256
d748041dc0149cc4539c2407042aaa6286795ec2b9d1722f0cb5484cca6764d4
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001070081.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))